UnitedHealth
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade UnitedHealth 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About UNH
UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx.
CEOSir Andrew Philip Witty
CEOSir Andrew Philip Witty
Employees400,000
Employees400,000
HeadquartersEden Prairie, Minnesota
HeadquartersEden Prairie, Minnesota
Founded1977
Founded1977
Employees400,000
Employees400,000
UNH Key Statistics
Market cap444.43B
Market cap444.43B
Price-Earnings ratio30.97
Price-Earnings ratio30.97
Dividend yield1.70%
Dividend yield1.70%
Average volume5.03M
Average volume5.03M
High today$486.77
High today$486.77
Low today$477.14
Low today$477.14
Open price$482.50
Open price$482.50
Volume4.10M
Volume4.10M
52 Week high$630.73
52 Week high$630.73
52 Week low$436.38
52 Week low$436.38
UNH News
TipRanks 5d
Vertex non-opioid pain drug picked up by UnitedHealthVertex Pharmaceuticals’ (VRTX) non-opioid pain drug Journavx was picked up by UnitedHealth’s (UNH) Optum on “Tier 3.” The insurer said, “Journavx has been place...
Seeking Alpha 5d
Vertex Pharma drops as UnitedHealth offers Tier 3 coverage for new pain medicineVertex Pharmaceuticals (NASDAQ:VRTX) ended a four-day winning streak on Thursday after UnitedHealth (NYSE:UNH) placed its new pain medication Journavx in a less...
Benzinga 7d
False Claims Act Case Against UnitedHealth Faces Dismissal RecommendationA Special Master has recommended granting UnitedHealth Group Inc’s UNH motion for summary judgment in a False Claims Act (FCA) case, concluding that the governm...
Analyst ratings
97%
of 31 ratingsBuy
96.8%
Hold
0%
Sell
3.2%
More UNH News
TipRanks 7d
Positive Outlook for UnitedHealth Amid Legal Developments and DOJ’s Weakened CaseJ.P. Morgan analyst Lisa Gill has maintained their bullish stance on UNH stock, giving a Buy rating yesterday. Lisa Gill’s rating is based on the recent develo...